Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | CYSLTR2 | Q9NS75 | 1/20 | 0.33 |
| ▸ | CYSLTR1 | Q9Y271 | 1/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.32 |
| ▸ | TRPV4 | Q9HBA0 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.31 |
| ▸ | CTSB | P07858 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9444005 | 0.88 | HSD11B1 (0.36) | HSD11B1ALDH1A1HSD17B10TDP1TRPV4 | |
| SCHEMBL8610746 | 0.82 | CA2 (0.44) | PTGES2CA2 | |
| SCHEMBL29469857 | 0.82 | CA2 (0.44) | PTGES2CA2 | |
| SCHEMBL776735 | 0.82 | MYC (0.39) | HSD11B1CYSLTR2CYSLTR1EPHX2MEN1 | |
| SCHEMBL9444041 | 0.82 | CTSB (0.33) | HSD11B1ALDH1A1HSD17B10TDP1PTGES2 | |
| SCHEMBL8905176 | 0.81 | HSD11B1 (0.36) | HSD11B1EPHX2MEN1KMT2ACA2 | |
| SCHEMBL8905178 | 0.81 | MYC (0.38) | HSD11B1CYSLTR2CYSLTR1EPHX2MEN1 | |
| SCHEMBL11254980 | 0.77 | ALDH1A1 (0.38) | ALDH1A1HSD17B10TDP1TRPV4PTGES2 | |
| SCHEMBL1415489 | 0.76 | MGLL (0.37) | ALDH1A1HSD17B10TDP1TRPV4PTGES2 | |
| SCHEMBL11249042 | 0.76 | TAAR1 (0.37) | ALDH1A1CYSLTR2CYSLTR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113336679-A | Synthesis method of triflusulfuron-methyl intermediate | 江苏省农用激素工程技术研究中心有限公司 | 2021-09-03 | — | — | CN | claimed |
| CN-113336679-A | Synthesis method of triflusulfuron-methyl intermediate | 江苏省农用激素工程技术研究中心有限公司 | 2021-09-03 | — | — | CN | disclosed |
| EP-1814849-A1 | HETEROCYCLIC COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE DOPAMINE D3 RECEPTOR | Abbott GmbH & Co. KG (DE) | 2007-08-08 | — | — | EP | disclosed |
| WO-2006040182-A1 | HETEROCYCLIC COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE DOPAMINE D3 RECEPTOR | ABBOTT GMBH & CO. KG (DE) | 2006-04-20 | — | — | WO | disclosed |
| US-5637763-A | Process for the preparation of substituted benzenes and benzene sulfonic acid and derivatives thereof and a process for the preparation of N,N'-substituted ureas | CIBA-GEIGY CORPORATION (US) | 1997-06-10 | — | — | US | disclosed |
| EP-0584043-B1 | Process for the preparation of substituted benzenes and benzene sulfonic acid and derivatives thereof and a process for the preparation of N'N-substituted ureas | CIBA GEIGY AG (CH) | 1996-10-30 | — | — | EP | disclosed |
| US-5508402-A | Process for the preparation of N,N'-substituted ureas | CIBA-GEIGY CORPORATION (US) | 1996-04-16 | — | — | US | disclosed |
| EP-0584043-A1 | Process for the preparation of substituted benzenes and benzene sulfonic acid and derivatives thereof and a process for the preparation of N'N-substituted ureas | CIBA-GEIGY AG (CH) | 1994-02-23 | — | — | EP | disclosed |